Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products.
The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 320.9K |
Three Month Average Volume | 14.9M |
High Low | |
Fifty-Two Week High | 153.93 USD |
Fifty-Two Week Low | 75.22 USD |
Fifty-Two Week High Date | 25 Mar 2024 |
Fifty-Two Week Low Date | 17 Oct 2023 |
Price and Volume | |
Current Price | 117.52 USD |
Beta | 1 |
Relative Price Change | |
Four Week Relative Price Change | 4.61% |
Thirteen Week Relative Price Change | -11.80% |
Twenty-Six Week Relative Price Change | -15.50% |
Fifty-Two Week Relative Price Change | -17.93% |
Year-to-Date Relative Price Change | -15.33% |
Price Change | |
One Day Price Change | 0.33% |
Thirteen Week Price Change | -5.61% |
Twenty-Six Week Price Change | -7.09% |
Five Day Price Change | -2.02% |
Fifty-Two Week Price Change | 2.84% |
Year-to-Date Price Change | 0.26% |
Month-to-Date Price Change | 9.85% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 25.84848 USD |
Book Value Per Share (Most Recent Quarter) | 25.72932 USD |
Tangible Book Value Per Share (Last Fiscal Year) | 5.77273 USD |
Tangible Book Value Per Share (Most Recent Quarter) | 7.02444 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 4.78076 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 37.85767 USD |
Revenue Per Share (Trailing Twelve Months) | 37.31545 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
Dividend Per Share (Trailing Twelve Months) | 0 USD |
Dividend Per Share (5 Year) | -99999.99 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | 1.50647 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | 1.47014 USD |
Normalized (Last Fiscal Year) | 1.98184 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | 1.54356 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.50073 USD |
Including Extraordinary Items (Last Fiscal Year) | 1.50647 USD |
Including Extraordinary Items (Trailing Twelve Months) | 1.47014 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 3.08712 USD |
Cash Per Share (Most Recent Quarter) | 2.43609 USD |
Cash Flow Per Share (Last Fiscal Year) | 3.32348 USD |
Cash Flow Per Share (Trailing Twelve Months) | 3.23034 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | 2.0555 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | 7 |
Cash Flow Revenue (Trailing Twelve Months) | 6 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | 4.06% |
Pretax Margin (Last Fiscal Year) | 4.30% |
Pretax Margin (5 Year) | 14.23% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 49.00% |
Gross Margin (Trailing Twelve Months) | 49.28% |
Gross Margin (5 Year) | 57.30% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | 6.66% |
Operating Margin (Trailing Twelve Months) | 6.52% |
Operating Margin (5 Year) | 14.85% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | 3.98% |
Net Profit Margin (Trailing Twelve Months) | 3.94% |
Net Profit Margin (5 Year) | 12.03% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | 7.20% |
Tangible Book Value (5 Year) | -19.79% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -50.57% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | 9.01% |
Revenue Growth (3 Year) | 19.00% |
Revenue Change (Trailing Twelve Months) | -7.76% |
Revenue Per Share Growth | 19.84% |
Revenue Growth (5 Year) | 21.43% |
Capital Spending Debt | |
Capital Spending (5 Year) | 31.06% |
Total Debt (5 Year) | -99,999.99% |
Dividends | |
Dividend Growth (3 Year) | -99,999.99% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 2.10% |
EPS Change (Trailing Twelve Months) | -31.24% |
EPS Growth (3 Year) | -15.37% |
EPS Growth (5 Year) | -28.61% |
EBITDA | |
EBITDA (5 Year) | 2.72% |
EBITDA (5 Year Interim) | 2.07% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -29.38% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 21 |
Price to Tangible Book (Most Recent Quarter) | 17 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | 982 |
Price to Free Cash Per Share (Trailing Twelve Months) | 57 |
Net Debt | |
Net Debt (Most Recent Quarter) | 652.0M |
Net Debt (Last Fiscal Year) | 743.0M |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 3 |
Price to Sales (Trailing Twelve Months) | 3 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | 80 |
PE Normalized (Last Fiscal Year) | 59 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 84 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 100 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 39 |
PE Including Extraordinary Items (Trailing Twelve Months) | 80 |
Dividends | |
Dividend Yield (5 Year) | -99,999.99% |
Dividend Yield | -99,999.99% |
Current Dividend Yield | 0.00% |
Price to Book | |
Price to Book (Last Fiscal Year) | 5 |
Price to Book (Most Recent Quarter) | 5 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 64 |
Long Term Debt to Equity (Most Recent Quarter) | 55 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | 0.00% |
Payout Ratio (Trailing Twelve Months) | 0.00% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 1 |
Quick Ratio (Most Recent Quarter) | 1 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 76 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 73 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 2 |
Current Ratio (Most Recent Quarter) | 2 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | 6.4M |
Free Cash Flow (Trailing Twelve Months) | 111.1M |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | 3 |
Net Interest Coverage (Trailing Twelve Months) | 3 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 66 |
Total Debt to Equity (Most Recent Quarter) | 57 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | 2.61% |
Return on Assets (Trailing Twelve Months) | 2.69% |
Return on Assets (5 Year) | 8.65% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | 6.03% |
Return on Equity (Trailing Twelve Months) | 5.93% |
Return on Equity (5 Year) | 13.44% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | 3.22% |
Return on Investment (Trailing Twelve Months) | 3.32% |
Return on Investment (5 Year) | 10.31% |